tiprankstipranks
Mereo Biopharma Group Plc (MREO)
NASDAQ:MREO
US Market
MREO
Mereo Biopharma Group Plc
RESEARCH TOOLSreports

Mereo Biopharma Group Plc (MREO) Financial Statements

865 Followers

Mereo Biopharma Group Plc Financial Overview

Mereo Biopharma Group Plc's market cap is currently $52.00M. The company's EPS TTM is $-0.01; its P/E ratio is -1.59; Mereo Biopharma Group Plc is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 500.00K$ 0.00$ 10.00M$ 0.00$ 49.21M
Gross Profit$ 367.00K$ 0.00$ 7.43M$ 257.44K$ 25.04M
Operating Income$ -40.50M$ -47.36M$ -28.42M$ -53.67M-
EBITDA$ -39.35M$ -40.80M$ -26.06M$ -39.98M$ 25.49M
Net Income$ -41.88M$ -43.25M$ -29.47M$ -42.12M$ 17.17M
Balance Sheet
Cash & Short-Term Investments$ 40.99M$ 69.80M$ 57.42M$ 68.18M$ 127.52M
Total Assets$ 45.92M$ 76.39M$ 66.50M$ 77.41M$ 170.96M
Total Debt$ 202.00K$ 6.43M$ 5.95M$ 15.37M$ 22.66M
Net Debt$ -40.79M$ -63.37M$ -51.47M$ -52.81M$ -104.08M
Total Liabilities$ 5.00M$ 15.42M$ 15.96M$ 26.01M$ 51.95M
Stockholders' Equity$ 40.92M$ 60.97M$ 50.54M$ 51.40M$ 119.01M
Cash Flow
Free Cash Flow$ -30.99M$ -33.53M$ -21.55M$ -48.83M$ -7.79M
Operating Cash Flow$ -30.97M$ -32.83M$ -21.13M$ -48.82M$ -7.07M
Investing Cash Flow$ -20.00K$ -699.00K$ -419.00K$ 1.99M$ -568.20K
Financing Cash Flow$ 327.00K$ 46.15M$ 7.97M$ 200.00K$ 104.80M
Currency in USD

Mereo Biopharma Group Plc Earnings and Revenue History

Income Statement >

Mereo Biopharma Group Plc Debt to Assets

Balance Sheet >

Mereo Biopharma Group Plc Cash Flow

Cash Flow >

Mereo Biopharma Group Plc Forecast EPS vs Actual EPS

Earnings >